BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 15853652)

  • 21. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
    Frecer V; Berti F; Benedetti F; Miertus S
    J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design.
    Kato R; Kaga C; Kunimatsu M; Kobayashi T; Honda H
    J Biosci Bioeng; 2006 Jun; 101(6):485-95. PubMed ID: 16935250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of topographical helix mimics as potent inhibitors of protein-protein interactions.
    Lao BB; Drew K; Guarracino DA; Brewer TF; Heindel DW; Bonneau R; Arora PS
    J Am Chem Soc; 2014 Jun; 136(22):7877-88. PubMed ID: 24972345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.
    Takasaki W; Kajino Y; Kajino K; Murali R; Greene MI
    Nat Biotechnol; 1997 Nov; 15(12):1266-70. PubMed ID: 9359109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel inhibitors of alpha 4 beta 1 integrin receptor interactions through library synthesis and screening.
    Souers AJ; Virgilio AA; Schürer SS; Ellman JA; Kogan TP; West HE; Ankener W; Vanderslice P
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2297-302. PubMed ID: 9873531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based design of an agonistic peptide targeting Fas.
    Yoshimori A; Takasawa R; Hayakawa A; Mizuno M; Yoshida J; Tanuma S
    Apoptosis; 2005 Mar; 10(2):323-9. PubMed ID: 15843893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Miniprotein Design: Past, Present, and Prospects.
    Baker EG; Bartlett GJ; Porter Goff KL; Woolfson DN
    Acc Chem Res; 2017 Sep; 50(9):2085-2092. PubMed ID: 28832117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scaffolds for blocking protein-protein interactions.
    Hershberger SJ; Lee SG; Chmielewski J
    Curr Top Med Chem; 2007; 7(10):928-42. PubMed ID: 17508924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De-novo design of complementary (antisense) peptide mini-receptor inhibitor of interleukin 18 (IL-18).
    Bhakoo A; Raynes JG; Heal JR; Keller M; Miller AD
    Mol Immunol; 2004 Nov; 41(12):1217-24. PubMed ID: 15482857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial chemistry techniques applied to nonpeptide integrin antagonists.
    Hoekstra WJ; Poulter BL
    Curr Med Chem; 1998 Jun; 5(3):195-204. PubMed ID: 9562602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide scanning for studying structure-activity relationships in drug discovery.
    Jamieson AG; Boutard N; Sabatino D; Lubell WD
    Chem Biol Drug Des; 2013 Jan; 81(1):148-65. PubMed ID: 23253136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The design, synthesis and application of stereochemical and directional peptide isomers: a critical review.
    Fischer PM
    Curr Protein Pept Sci; 2003 Oct; 4(5):339-56. PubMed ID: 14529528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides.
    Gurrath M; Müller G; Kessler H; Aumailley M; Timpl R
    Eur J Biochem; 1992 Dec; 210(3):911-21. PubMed ID: 1483474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geometry of nonbonded interactions involving planar groups in proteins.
    Chakrabarti P; Bhattacharyya R
    Prog Biophys Mol Biol; 2007; 95(1-3):83-137. PubMed ID: 17629549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and assay of retro-α4β1 integrin-targeting motifs.
    Dattoli SD; De Marco R; Baiula M; Spampinato S; Greco A; Tolomelli A; Gentilucci L
    Eur J Med Chem; 2014 Feb; 73():225-32. PubMed ID: 24412498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.